A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder
published in: Psychopharmacology
date of publication: 2013-05-03
main subject: placebo, attention deficit hyperactivity disorder, attention
Cites articles 57
- 2008-02-01
Date
Title
Article - wd:Q37337365